Immune Diseases Flashcards
(83 cards)
T/F: IMHA is almost always secondary to another disease
False - it is almost always a primary disorder
What are the 4 classic labratory findings of IMHA
-Regenerative anemia
-Spherocytosis
-RBC autoagglutination
-Hyperbilirubinemia
What onset is IMHA typically
Subacute onset: depression, weakness, inappetance, icterus
What are the primary differentials for dogs with severe regenerative anemia
- Blood loss (>3d duration)
-RBC destruction, IMHA
-RBC destruction, infectious (Babesia)
-RBC lysis, toxin (Zn, low P)
What infectious agent can cause RBC destruction
Babesia
What is not an important prognostic factor of IMHA
-Concurrent thrombocytopenia
-Severity of anemia
-Severity of leukocytosis
-Elevated BUN
-Hyperbilirubinemia
-Monocytosis
-Severity of anemia
Anemia from IMHA is typically regenerative or non-regenerative
Regenerative
What are differentials for anemia
-Anemia of chronic disease
-Bone marrow infiltrative disease
-Iron deficiency anemia
-Chronic blood loss anemia
-Pure red cell aplasia
-Immune destruction of red blood cell precursors (PIMA)
What diagnostic tests do we consider for patients presenting for non-regenerative anemia
-Serology for tickborne infections
-Coombs test or RBC flow cytometry
-Bone marrow aspirate or biopsy
-Fecal occult blood test
-GI barium series (to look for ulcers if occult blood positive)
immune attack target at RBC precursors in bone marrow
mature cells never leave marrow
non-regenerative because reticulocytes killed off
Precursor-targeted immune mediated anemia (PIMA)
PIMA usually responds to
long-term immune suppressive therapy with steroids and JAK inhibitors
Why do we consider IMHA two diseases in one
Most dogs with IMHA develop concurrent thromboembolic disease
clinical thromboembolism reflected by thrombocytopenia, leukocytosis, abnormal coagulation test
What is the primary cause of death in most dogs with IMHA
Thromboembolism
What is the two-fold treatment approach for patients with IMHA
1) Immunosuppression: stop RBC destruction by inactivating macrophages and lymphocytes
2) Anticoagulation: Reduce risk of thromboembolic disease
Why do dogs with IMHA typically develop thromboembolic disease
likely do to excessive plately activation or monocyte activation and tissue factor release
What is a major prognosis factor of IMHA
hyperbilirubinemia
Treating IMTP requires
quick decisions bc diagnostically difficult and life-threatening
What are ranked differentials for thrombocytopenia
-Immune mediated thrombocytopenia (primary)
-Platelet consumption (secondary to thromboembolic disease)
-Drug reaction
-Bone marrow toxicity or myelophthisis
-Chronic ehrlichiosis
-Disseminated intravascular coagulation (DIC)
Primary IMTP mediated in most cases by
anti-platelet antibodies
in some patients, platelet destruction is independent of antibodies (APA-negative)
Immune destruction of platelets or _____ can cause thrombocytopenia
megakaryocyte
What is a second major differential for severe thrombocytopenia, after IMTP
thromboembolic disease
How do you diagnose IMTP
-Typical clinical findings
-Detection of anti-platelet antibodies (APA) can work in some patients but some IMTP patients are APA negative
-Platelet size (MPV) distribution may be helpful
-Bone marrow examination indicated if APA-negative and other immune causes of thrombocytopenia is ruled out
What is indicated if APA-negative and other immune causes of thrombocytopenia is ruled out
Bone marrow examination
How do we treat IMTP if sure of diagnosis
-Intial high doses of prednisone (1-2mg/kg/day)
-Consider high-dose IV methylprednisolone for life-threatening IMTP
-Often add mycophenolate or cyclosporine
-Single IV treatment with purified immune globulins (IVIG)